Development of Biomarkers for Monitoring Menopause in Women
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20+
SponsorFu Jen Catholic University Hospital
About this trial
This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.
Eligibility criteria
Qualifiers
Biological female, age order than 20 years old.
Disqualifiers
Person with cancer.
Person with any known acute or chronic infection.
Person with known chronic illness under follow up or treatment.
Pregnancy, one year withing delivery, under breast feeding, or three months within breast feeding.
Trial design
Treatments tested in this trial
- Blood Sample Collection
Treatment groups
100 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov